RxDoctor Payments Data

Alan Brook, MD

Diagnostic Radiology · Bronx, NYNPI 1720171952

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (43.4%), other and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 88.0% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $444,112 and has fallen 90.8% since, to $40,742 in 2025. Among diagnostic radiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$930,389in general payments, 2019–2025

Across 570 payments — averaging $1632.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$818K
  • Stryker$33K
  • Nevro Corp.$25K
  • Rapid Medical Ltd$10K
  • Canary Medical USA LLC$10K
  • Philips North America LLC$9K
  • plus $25K from 24 others
$86,886in research payments, 2019–2025

Across 22 payments — averaging $3949.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Balt USA, LLC$49K
  • Lenoss Medical Inc$38K

What the payments were for

  • Royalty or licence$403,67543%
  • Consulting fees$123,19313%
  • Speaking & faculty fees$51,1295%
  • Travel & lodging$75,6548%
  • Food & beverage$23,5783%
  • Other$253,16027%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$930,389 in reported general payments places this provider in the 95th percentile of 2,530 diagnostic radiology providers in New York.

See all diagnostic radiology providers in New York

Medicare billing

Part B allowed, 2024
$89,879
Medicare patients
307
Services billed
695

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin86$705
Methylprednisolone14$111
Naproxen17$100
ClopidogrelClopidogrel Bisulfate21$73
Meloxicam11$3

Paid to pharmacies, not to this prescriber.

Other diagnostic radiology in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →